These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 19256150)

  • 1. [Vegetable protein diets with or without non-absorbable antibiotics for the treatment of chronic portal systemic encephalopathy].
    Uribe M; Vargas F; Villalobos A; Ramos GC; Briones A; Galvan E; Ramos MH; Guevara L
    Rev Invest Clin; 1990 Jul; 42 Suppl():120-6. PubMed ID: 19256150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of chronic portal--systemic encephalopathy with vegetable and animal protein diets. A controlled crossover study.
    Uribe M; Márquez MA; Garcia Ramos G; Ramos-Uribe MH; Vargas F; Villalobos A; Ramos C
    Dig Dis Sci; 1982 Dec; 27(12):1109-16. PubMed ID: 6756833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary protein supplementation from vegetable sources in the management of chronic portal systemic encephalopathy.
    Keshavarzian A; Meek J; Sutton C; Emery VM; Hughes EA; Hodgson HJ
    Am J Gastroenterol; 1984 Dec; 79(12):945-9. PubMed ID: 6391154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial effect of vegetable protein diet supplemented with psyllium plantago in patients with hepatic encephalopathy and diabetes mellitus.
    Uribe M; Dibildox M; Malpica S; Guillermo E; Villallobos A; Nieto L; Vargas F; Garcia Ramos G
    Gastroenterology; 1985 Apr; 88(4):901-7. PubMed ID: 2982694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effect of carbohydrate maldigestion induced by a disaccharidase inhibitor (AO-128) in the treatment of chronic portal-systemic encephalopathy. A double-blind, randomized, controlled trial.
    Uribe M; Morán S; Poo JL; Méndez-Sánchez N; Guevara L; García-Ramos G
    Scand J Gastroenterol; 1998 Oct; 33(10):1099-106. PubMed ID: 9829367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of portal systemic encephalopathy: standard and new treatments.
    Marín E; Uribe M
    Rev Invest Clin; 1990 Jul; 42 Suppl():141-8. PubMed ID: 19256154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sodium benzoate in portal-systemic-encephalopathy-induced blood ammonia normalization and clinical improvement. Interim report of a double-blind multicenter trial].
    Uribe M; Bosques F; Marín E; Cervera E; Gil S; Luis Poo J; Garcia Compeán D; Santoyo R; Huerta E; García-Ramos G; Cadena M; Merikansky A; Robledo J; Cortés M; Guevara A; López N; Aguilar A; Alejandra Ochoa E
    Rev Invest Clin; 1990 Jul; 42 Suppl():149-54. PubMed ID: 19256155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.
    Kircheis G; Nilius R; Held C; Berndt H; Buchner M; Görtelmeyer R; Hendricks R; Krüger B; Kuklinski B; Meister H; Otto HJ; Rink C; Rösch W; Stauch S
    Hepatology; 1997 Jun; 25(6):1351-60. PubMed ID: 9185752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of dietary protein manipulation in subclinical portal-systemic encephalopathy.
    de Bruijn KM; Blendis LM; Zilm DH; Carlen PL; Anderson GH
    Gut; 1983 Jan; 24(1):53-60. PubMed ID: 6336714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standard and higher doses of bromocriptine for severe chronic portal-systemic encephalopathy.
    Uribe M; García-Ramos G; Ramos M; Valverde C; Márquez MA; Farca A; Guevara L
    Am J Gastroenterol; 1983 Aug; 78(8):517-22. PubMed ID: 6881119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vegetable versus animal protein diet in cirrhotic patients with chronic encephalopathy. A randomized cross-over comparison.
    Bianchi GP; Marchesini G; Fabbri A; Rondelli A; Bugianesi E; Zoli M; Pisi E
    J Intern Med; 1993 May; 233(5):385-92. PubMed ID: 8068051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial.
    Conn HO; Leevy CM; Vlahcevic ZR; Rodgers JB; Maddrey WC; Seeff L; Levy LL
    Gastroenterology; 1977 Apr; 72(4 Pt 1):573-83. PubMed ID: 14049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rifaximin versus neomycin on hyperammoniemia in chronic portal systemic encephalopathy of cirrhotics. A double-blind, randomized trial.
    Pedretti G; Calzetti C; Missale G; Fiaccadori F
    Ital J Gastroenterol; 1991 May; 23(4):175-8. PubMed ID: 1751811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactitol, a second-generation disaccharide for treatment of chronic portal-systemic encephalopathy. A double-blind, crossover, randomized clinical trial.
    Uribe M; Toledo H; Perez F; Vargas F; Gil S; Garcia-Ramos G; Ravelli GP; Guevara L
    Dig Dis Sci; 1987 Dec; 32(12):1345-53. PubMed ID: 3319453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of chronic portal-systemic encephalopathy with lactose in lactase-deficient patients.
    Uribe M; Márquez MA; García-Ramos G; Escobedo V; Murillo H; Guevara L; Lisker R
    Dig Dis Sci; 1980 Dec; 25(12):924-8. PubMed ID: 7004808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo lactose and lactulose effects on colonic fermentation and portal-systemic encephalopathy parameters.
    Uribe-Esquivel M; Moran S; Poo JL; Muñoz RM
    Scand J Gastroenterol Suppl; 1997; 222():49-52. PubMed ID: 9145447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of hepatic encephalopathy using a modified high-calorie high-protein diet.
    Gheorghe L; Iacob R; Vădan R; Iacob S; Gheorghe C
    Rom J Gastroenterol; 2005 Sep; 14(3):231-8. PubMed ID: 16200232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lactilol (Importal, 10g in powder made by ZYMA) in the treatment of portal systemic encephalopathy].
    Boca M; Duris I; Kolibás E; Kratochvíl'ová E
    Vnitr Lek; 1996 Apr; 42(4):234-8. PubMed ID: 8693708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of hepatic encephalopathy with oral zinc supplementation: a long-term treatment.
    Bresci G; Parisi G; Banti S
    Eur J Med; 1993; 2(7):414-6. PubMed ID: 8258031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rifaximin ameliorates hepatic encephalopathy and endotoxemia without affecting the gut microbiome diversity.
    Kaji K; Takaya H; Saikawa S; Furukawa M; Sato S; Kawaratani H; Kitade M; Moriya K; Namisaki T; Akahane T; Mitoro A; Yoshiji H
    World J Gastroenterol; 2017 Dec; 23(47):8355-8366. PubMed ID: 29307995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.